Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medivation falls after analyst says Xtandi must overcome obstacles
The Fly on the Wall
Thursday, February 28, 2013 - 11:27am
tags:
Medivation, Xtandi, prostate cancer
Why Expect More Price Swings From These 4 Biotechs
TheStreet.com
Thursday, February 28, 2013 - 11:26am
tags:
Dendreon, Keryx, Oncolytics, Vivus
Valeant Earnings Seen Rising As Firm Digests Medicis
Investors.com
Thursday, February 28, 2013 - 10:55am
tags:
earnings, Valeant Pharmaceuticals, Medicis
Pernix Therapeutics Receives FDA Approvals
Yahoo
Thursday, February 28, 2013 - 10:54am
tags:
FDA, Pernix, Mefenamic Acid, Vituz
Bayer Sees 2013 Sales Growth on Drugs, Crop Chemicals
Bloomberg
Thursday, February 28, 2013 - 10:52am
tags:
earnings, Bayer
Mylan to buy injectable drugs unit of India's Strides for $1.6 bln
Reuters
Thursday, February 28, 2013 - 10:50am
tags:
Mylan, M&A, India, Strides Arcolab, injectables, Agila
Niacin-statin combination tied to skin, muscle side effects
Reuters
Thursday, February 28, 2013 - 10:49am
tags:
statins, niacin, Merck, Tredaptive
Why Sarepta Therapeutics Shares Shot Higher
Motley Fool
Wednesday, February 27, 2013 - 5:25pm
tags:
Sarepta, Duchenne Muscular Dystrophy, eteplirsen
This FDA Approval Is Actually a Big Deal
Motley Fool
Wednesday, February 27, 2013 - 12:40pm
tags:
Kadcyla, Roche, Immunogen
Solid Where It Matters: Questcor To Climb On Strong Quarter And Dividend Raise
Seeking Alpha
Wednesday, February 27, 2013 - 12:30pm
tags:
earnings, Questcor
ViroPharma Earnings: Here’s Why Investors are Not Happy Now
Wall St. Cheat Sheet
Wednesday, February 27, 2013 - 12:29pm
tags:
earnings, ViroPharma
Is Takeda Interested In Aastrom Bio?
Seeking Alpha
Wednesday, February 27, 2013 - 12:28pm
tags:
Takeda, Aastrom Biosciences, M&A
US Supreme Court rules against Amgen in class action
Reuters
Wednesday, February 27, 2013 - 12:26pm
tags:
Amgen, Supreme Court
The Sum Of JNJ's Parts: Medical Devices
Motley Fool
Wednesday, February 27, 2013 - 12:17pm
tags:
JNJ, devices
Roche Peels Back The Curtain On Clinical Trial Data
Pharmalot
Wednesday, February 27, 2013 - 12:16pm
tags:
Roche, clinical trials
FDA approves a pill for post-menopausal sex problems
LA Times, CA
Wednesday, February 27, 2013 - 12:15pm
tags:
FDA, Osphena, dyspareunia
Amarin: The More You Know The Fishier It Gets
Seeking Alpha
Wednesday, February 27, 2013 - 12:13pm
tags:
Amarin, Vascepa, Acasti
It's Time for This Big Pharma to Save Its Future
Motley Fool
Wednesday, February 27, 2013 - 12:11pm
tags:
AstraZeneca
Tackling Cancer: The Current and Upcoming Players
Motley Fool
Wednesday, February 27, 2013 - 11:36am
tags:
Life Technologies, JNJ, Pharmacyclics
Royalty Pharma plans to tap Elan investors on offer -source
Reuters
Wednesday, February 27, 2013 - 11:34am
tags:
Elan, investors, M&A, Royalty Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.